Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00484146
Status:
TERMINATED
Last Update Posted:
2017-02-09
First Post:
2007-06-07
Brief Title:
Alterations of Immunologic Mediators During Severe Sepsis
Sponsor:
Klinikum St Georg gGmbH
Organization:
Klinikum St Georg gGmbH
Study Overview
Official Title:
Alterations of Immunologic Mediators During Severe Sepsis
Status:
TERMINATED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
anticipated number of patients could not be reached
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LAVISS_01
Brief Summary:
Severe sepsis induces significant changes in expression of insulin- and toll-like receptors cytokines markers of apoptosis and activation of t- and b-lymphocytes
Detailed Description:
In patients at early stage of severe sepsis we investigate the expression of pro- and anti-inflammatory cytokines chemokines adhesion-molecules toll-like receptors insulin-receptors markers of apoptosis und of t- and b-cell-activation on a mRNA level
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ISRCTN34508816 | None | None | None |